TWM
CC icon

TriaGen Wealth Management’s Chemours CC Stock Holding History

TriaGen Wealth Management’s Portfolio CC Stock Details CC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$864K Sell
42,081
-124
-0.3% -$2.84K 0.22% 104
2026
Q1 		$930K Buy
+42,205
New +$735K 0.25% 84

Other funds holding CC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CCPM
Cooper Creek Partners Management New York $4.21B AUM 44.81% 1-Year Est. Return
VOYA Investment Management
VOYA Investment Management Atlanta, Georgia $116B AUM 61.47% 1-Year Est. Return

TriaGen Wealth Management's CC Position: Q2 2026 in Review

TriaGen Wealth Management reduced its Chemours (CC) stake by 0.29% in Q2 2026, selling an estimated $2.84K and leaving 42,081 shares worth $864K. The position accounts for 0.22% of the portfolio, ranked #104.

TriaGen Wealth Management first reported a position in CC in Q1 2026 and has held it in 2 quarters since. The position peaked at $930K in Q1 2026. 469 funds tracked by Wall St. Rank hold CC as of Q2 2026.

  • TriaGen Wealth Management held 42,081 shares of Chemours worth $864K as of Q2 2026.
  • TriaGen Wealth Management sold 124 Chemours shares in Q2 2026, an estimated $2.84K.
  • Chemours made up 0.22% of TriaGen Wealth Management's portfolio in Q2 2026, its #104 holding.
  • TriaGen Wealth Management first reported a position in Chemours in Q1 2026 and has held it in 2 quarters since.
  • TriaGen Wealth Management's Chemours position peaked at $930K in Q1 2026.
  • 469 funds tracked by Wall St. Rank held Chemours as of Q2 2026.

Based on TriaGen Wealth Management's 13F filing for Q2 2026, filed 21 Jul 2026.